HCV-IN-37

Modify Date: 2024-01-14 14:25:52

HCV-IN-37 structure	Common Name	HCV-IN-37
	CAS Number	2425804-98-2	Molecular Weight	515.64
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₁H₃₅F₂N₅	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HCV-IN-37

HCV-IN-37 (Compound 3d) is a potent inhibitor of HCV. HCV-IN-37 is orally available and long-lasting in rat plasma after oral administration to rats by a single dose of 15 mg/kg. The high potency of active derivative HCV-IN-37 is primarily driven by the inhibitory effect on the virus entry stage[1].

Name	HCV-IN-37

Description	HCV-IN-37 (Compound 3d) is a potent inhibitor of HCV. HCV-IN-37 is orally available and long-lasting in rat plasma after oral administration to rats by a single dose of 15 mg/kg. The high potency of active derivative HCV-IN-37 is primarily driven by the inhibitory effect on the virus entry stage[1].
Related Catalog	Signaling Pathways >> Anti-infection >> HCV Research Areas >> Infection
Target	EC50: 0.005 ± 0.005 μM (HCV)[1]
References	[1]. Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65(3):2107-2121.

Molecular Formula	C₃₁H₃₅F₂N₅
Molecular Weight	515.64

HCV-IN-37

Use of HCV-IN-37

Names

HCV-IN-37 Biological Activity

Chemical & Physical Properties